TY - JOUR
T1 - Mediation of Adverse Pregnancy Outcomes in Autoimmune Conditions by Pregnancy Complications
T2 - A Mediation Analysis of Autoimmune Conditions and Adverse Pregnancy Outcomes
AU - Bandoli, Gretchen
AU - Singh, Namrata
AU - Strouse, Jennifer
AU - Baer, Rebecca J.
AU - Donovan, Brittney M.
AU - Feuer, Sky K.
AU - Nidey, Nichole
AU - Ryckman, Kelli K.
AU - Jelliffe-Pawlowski, Laura L.
AU - Chambers, Christina D.
N1 - Publisher Copyright:
© 2019, American College of Rheumatology
PY - 2020/2/1
Y1 - 2020/2/1
N2 - Objective: Autoimmune conditions are associated with an increased risk of adverse pregnancy complications and outcomes, suggesting that pregnancy complications may mediate the excess risk. We performed a causal mediation analysis to quantify the mediated effects of autoimmune conditions on adverse pregnancy outcomes. Methods: We queried a California birth cohort created from linked birth certificates and hospital discharge summaries. From 2,963,888 births, we identified women with rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), psoriasis, and inflammatory bowel disease (IBD). Pregnancy complications included preeclampsia/hypertension, gestational diabetes mellitus, and infection in pregnancy. Adverse pregnancy outcomes were preterm birth, cesarean delivery, and small for gestational age. We performed a mediation analysis to estimate the total effects of each autoimmune condition and adverse pregnancy outcome and the indirect effects through pregnancy complications. Results: All 4 autoimmune conditions were associated with preterm birth and cesarean delivery, and RA, SLE, and IBD were associated with offspring that were small for gestational age. The strongest mediator of RA, SLE, and psoriasis was preeclampsia/hypertension, accounting for 20–33% of the excess risk of preterm births and 10–19% of excess cesarean deliveries. Gestational diabetes mellitus and infections generally mediated <10% of excess adverse pregnancy outcomes. Of the 4 autoimmune conditions, selected pregnancy complications mediated the least number of adverse pregnancy outcomes among women with IBD. Conclusion: We found evidence that some excess risk of adverse pregnancy outcomes is mediated through pregnancy complications, particularly preeclampsia/hypertension. Quantifying excess risk and associated pathways provides insight into the underlying etiologies of adverse pregnancy outcomes and can inform intervention strategies.
AB - Objective: Autoimmune conditions are associated with an increased risk of adverse pregnancy complications and outcomes, suggesting that pregnancy complications may mediate the excess risk. We performed a causal mediation analysis to quantify the mediated effects of autoimmune conditions on adverse pregnancy outcomes. Methods: We queried a California birth cohort created from linked birth certificates and hospital discharge summaries. From 2,963,888 births, we identified women with rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), psoriasis, and inflammatory bowel disease (IBD). Pregnancy complications included preeclampsia/hypertension, gestational diabetes mellitus, and infection in pregnancy. Adverse pregnancy outcomes were preterm birth, cesarean delivery, and small for gestational age. We performed a mediation analysis to estimate the total effects of each autoimmune condition and adverse pregnancy outcome and the indirect effects through pregnancy complications. Results: All 4 autoimmune conditions were associated with preterm birth and cesarean delivery, and RA, SLE, and IBD were associated with offspring that were small for gestational age. The strongest mediator of RA, SLE, and psoriasis was preeclampsia/hypertension, accounting for 20–33% of the excess risk of preterm births and 10–19% of excess cesarean deliveries. Gestational diabetes mellitus and infections generally mediated <10% of excess adverse pregnancy outcomes. Of the 4 autoimmune conditions, selected pregnancy complications mediated the least number of adverse pregnancy outcomes among women with IBD. Conclusion: We found evidence that some excess risk of adverse pregnancy outcomes is mediated through pregnancy complications, particularly preeclampsia/hypertension. Quantifying excess risk and associated pathways provides insight into the underlying etiologies of adverse pregnancy outcomes and can inform intervention strategies.
UR - http://www.scopus.com/inward/record.url?scp=85078308192&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85078308192&partnerID=8YFLogxK
U2 - 10.1002/acr.24037
DO - 10.1002/acr.24037
M3 - Article
C2 - 31373768
AN - SCOPUS:85078308192
SN - 0004-3591
VL - 72
SP - 256
EP - 264
JO - Arthritis and Rheumatism
JF - Arthritis and Rheumatism
IS - 2
ER -